NCT06363617

Implementation of the Fatty Liver Index in Primary Care

Implementation of the Fatty Liver Index in Primary Care for Patients at Risk of Hepatic Steatosis to Optimize Clinical Control: Randomized Clinical Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 434 (actual)
• Sponsor: Consorci Sanitari de l'Alt Penedès i Garraf · Academic / Other
• Sex: All
• Age: 14 Years
• Healthy volunteers: Not accepted

Summary

This trial aims to evaluate the impact on cardiovascular risk control in individuals in risk of being affected by hepatic steatosis through the implementation of a screening test (Fatty Liver Index) in Primary Care. Medical teams in a primary care center will be divided into 2 groups, with one group using the screening test in their clinical practice. The number of interventions on cardiovascular risk occurring in patients attended by each group of medical teams will be evaluated and compared.

Conditions

• Hepatic Steatosis
• Overweight and Obesity

Interventions

Type	Name	Description
OTHER	FLI	Health professionals will use the FLI test in their clinical practice

Timeline

• Start date: 2024-05-02
• Primary completion: 2025-02-01
• Completion: 2025-02-01
• First posted: 2024-04-12
• Last updated: 2025-06-29

Locations

1 site across 1 country: Spain